STAGE IIIA BREAST CANCER AJCC V7

This study is testing whether a shorter, 3-week radiation schedule is as effective as the standard 5-week schedule for preventing breast cancer from returning in the lymph nodes. It will also closely compare side effects, especially arm swelling (lymphedema), between the two grou…

This study is testing whether a comprehensive lifestyle program can improve outcomes for people with stage II or III breast cancer who are undergoing radiation therapy. The program includes dietary coaching, exercise, stress management, and social support. Researchers want to see…

This early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …

This study is testing whether taking two oral drugs, cediranib and olaparib, together can help control advanced cancers that have spread or cannot be surgically removed. It is for adults with specific types of advanced lung, breast, or pancreatic cancer who have already tried at …

This study is testing whether a newer hormone therapy drug called Z-Endoxifen works better than the standard drug tamoxifen for controlling advanced breast cancer. It involves 81 postmenopausal women whose cancer has spread, is fueled by estrogen, and has stopped responding to in…

This study is testing whether a form of acupuncture using mild electrical pulses can help reduce long-term pain in women who have been treated for early-stage breast cancer. It involves 111 participants who are randomly assigned to receive either real electroacupuncture, a fake v…